Ribosome Homeostasis Regulated by SETD2 Preserves Intestinal Epithelial Barrier
Advanced Science · 2026
DOI: 10.1002/advs.202508168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Hanyu Rao und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, School of Medicine and School of Biomedical Engineering, Ren Ji Hospi…. Hauptthemen laut MEDLINE: Ribosomes, Histone-Lysine N-Methyltransferase, Intestinal Mucosa, Homeostasis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Interdisciplinary Program of Shanghai Jiao Tong University.
Abstract (Originalsprache)
Strict regulation of epithelial cells is crucial for maintaining intestinal barrier integrity and preventing intestinal diseases. While transcriptional regulation is well recognized as vital in this process, translational regulation is equally important. SETD2, a methyltransferase, is involved in transcriptional regulation to maintain intestinal epithelial barrier function. However, its role in translation remains largely unexplored. Here, we found SETD2 deficiency leads to the downregulation of ribosome biogenesis progress coupled with transcriptome‐proteome discordance. Further ribosome profiling sequencing analyses showed reduced translational efficiency of cell adhesion and junction signatures in impaired intestinal epithelial barrier. Mechanistically, SETD2 ablation causes dysregulation and recruitment disorders of ribosome biogenesis factors, impairing the composition and distribution of ribosomal proteins. This disruption of ribosome biogenesis and homeostasis results in translational disorder of barrier maintenance genes, thereby compromising the intestinal barrier. Collectively, our findings unveil a previously unappreciated role of ribosome biogenesis and translational regulation in safeguarding intestinal epithelial barrier, and disclose a previously undiscovered role of SETD2 in modulating ribosome homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, School of Medicine and School of Biomedical Engineering, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China.
- State Key Laboratory of Systems Medicine for Cancer, Institute for Personalized Medicine and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China.
- Department of Anesthesiology and Surgical Intensive Care Unit, School of Medicine and School of Biomedical Engineering, Xinhua Hospital, Shanghai Jiao Tong University, Shanghai, China.
- Department of Oncology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Li Li
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Interdisciplinary Program of Shanghai Jiao Tong University
- Science and Technology Plan Project of Wenzhou Municipality
- National Key Research and Development Program of China
Zitieren
APA
Rao, H., Wang, A., Xu, Y., Feng, W., Ma, C., Wang, Z., Zhang, W., Su, W., Xiao, X., Gao, W. Q., Ding, X., & Li, L. (2026). Ribosome Homeostasis Regulated by SETD2 Preserves Intestinal Epithelial Barrier. Advanced Science. https://doi.org/10.1002/advs.202508168
Vancouver
Rao H, Wang A, Xu Y, Feng W, Ma C, Wang Z, et al. Ribosome Homeostasis Regulated by SETD2 Preserves Intestinal Epithelial Barrier. Advanced Science. 2026. doi:10.1002/advs.202508168
BibTeX
@article{Rao2026,
author = {Rao, Hanyu and Wang, Aiting and Xu, Yue and Feng, Wenxin and Ma, Chunxiao and Wang, Ziyi and Zhang, Wei and Su, Wenqiong and Xiao, Xiuying and Gao, Wei-Qiang and Ding, Xianting and Li, Li},
title = {Ribosome Homeostasis Regulated by SETD2 Preserves Intestinal Epithelial Barrier},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202508168}
}
EUVIMED